Invacare Corporation (IVC)

LONDON--(BUSINESS WIRE)--Rhône, a global private equity firm, has completed the acquisitions of Invacare Holdings S.ar.l. (Invacare Europe and APAC) and Direct Healthcare Group (DHG) through holding companies held by its Fund VI, combining the two businesses and associated brands to create DHCare, which will be one of the international leaders in designing, manufacturing and distributing medical devices in the mobility and post-acute care sectors. The transaction completed on the 30th January 2.

Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "Electric Wheelchair Market Forecast 2024-2031" report has been added to ResearchAndMarkets.com's offering. The Global Electric Wheelchair Market is experiencing robust expansion, valued at US$ 7.3 billion in 2023, and projected to grow at a CAGR of 11.37% from 2024 to 2031, reaching US$ 16.41 billion in 2031. The electric wheelchair market has experienced significant growth driven by technological advancements and an increasing focus on accessibility. Key factors propelling market expansion include improvements in battery technology, making electric wheelchairs more reliable and longer-lasting.

Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Electric Wheelchair Market Report By Age group, Product, End Users, Countries and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering. The Electric Wheelchair Market is expected to experience substantial growth, with its market size projected to increase from US$ 3.64 billion in 2023 to US$ 7.82 billion by 2032. The growth represents an average annual increase of 8.88% from 2024 to 2032. Driving forces for electric wheelchair technologies

TAIPEI, June 12, 2023 /PRNewswire/ — StickeyGO, a joint venture company established by KryptoGO, YGG Japan (YGGJ), and Infinity Ventures Crypto (IVC), is thrilled to announce the launch of Stickey Wallet, a ground-breaking wallet specifically designed for the GameFi industry. Despite the rising popularity of GameFi, many players often associate it with complex operations such […]...

NEW YORK--( BUSINESS WIRE )--The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common shares of Invacare Corporation (the “Company”) — ticker symbol IVC — from the NYSE. Trading in the Company's common shares will be suspended immediately.

Invacare Corp. IVC, -2.25% said Wednesday it and two of its U.S.-based subsidiaries have filed for bankruptcy, as it implements a refinancing aimed at reducing net debt by about 65%. The stock is currently halted for news.

ELYRIA, Ohio--( BUSINESS WIRE )--Invacare Corporation (NYSE: IVC) (“Invacare” or “the company”), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced actions to strengthen the company and position it for long-term success.

ELYRIA, Ohio--( BUSINESS WIRE )--Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announced the consummation of an additional draw of $5,500,000 of term loans under to its Credit Agreement with certain funds managed by Highbridge Capital Management LLC (“Highbridge”), as of December 23, 2022.

Fintel reports that Rosen Steven H and his Azurite Management LLC filed a 13D/A form with the SEC disclosing ownership of 3,665,233 shares of Invacare Corporation (IVC cnx.cmd.push(function() {var videoId = decodeURIComponent(""); cnx({ playerId: "0a52d238-33b5-4c04-ba5e-323e192cfbe8", mediaId: videoId}).render("b8b49474e42e4a61905a1353db504ac9"); });).

ELYRIA, Ohio--( BUSINESS WIRE )--Invacare Corporation (NYSE: IVC) announced today that its Board of Directors has named Geoffrey P. Purtill as President and Chief Executive Officer, roles that he has served on an interim basis since August 28, 2022.

Invacare Corporation (NYSE:IVC ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Lois Lee - Director of Treasury, Investor Relations and Corporate Communications Geoffrey Purtill - Interim President and Chief Executive Officer Kathy Leneghan - Senior Vice President and Chief Financial Officer Conference Call Participants Peter Lukas - CJS Securities Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Invacare Third Quarter 2022 Conference Call and Webcast.

Invacare (IVC) delivered earnings and revenue surprises of -45.95% and 13.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended September 30, 2022.

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the third quarter ended September 30, 2022, after the market closes on Monday, November 7, 2022. The company will provide a live conference call and webcast to discuss these financial results on Tuesday, November 8, 2022, at 8:30 AM ET. Investors and other interested parties may access the webcast and conference call in the following ways: Those wishing to participate via webcast can register and access the event at https://events.q4inc.com/attendee/918973030 Those wishing to participate via telephone can dial 844-200-6205 (U.S. and Canada) or 929-526-1599 (international callers) and enter Conference ID Code 542322. A copy of the webcast slide deck will be posted to https://global.invacare.com/investor-relations prior to the webcast and an archive of the webcast will be posted 24 hours after the call. A recording of the conference call can be accessed by dialing 929-458-6194 and entering the Conference ID Code 071740, through November 22, 2022. About Invacare Corporation Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific. For more information about the company and its products, visit Invacare's website at www.invacare.com.

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE:IVC) (“Invacare” or the “company”) announced today the consummation of additional draws of an aggregate of $18,500,000 of term loans pursuant to its Credit Agreement with certain funds managed by Highbridge Capital Management LLC (“Highbridge”). Additional commitments of $19,500,000 remain available under the Amended Highbridge Loan Agreement, subject to the satisfaction of certain conditions set forth therein. Concurrently with the addi